Treatment Strategies for Plasma Cell Myeloma

Plasma cell myeloma

Myeloma is the most common neoplasm of bone.The majority is diagnosed with a bone marrow aspirate, rather than a bone biopsy. Most patients have disseminated disease, associated with a poor prognosis. Some have solitary myeloma with a more favourable clinical course but eventually, most become multifocal. A small percentage of patients have sclerotic bone lesions, which may be associated with p...

Orbital plasma cell myeloma.

Orbital plasma cell myeloma is a rare condition. In a review of 222 intraorbital tumours, Forrest (1949) found only one case, and Offret (I951) reported two cases in a series of 676 orbital tumours. Clarke (I 953) emphasized the differentiation between the plasma cell myeloma of myelomatosis and the benign plasma cell tumour produced by chronic inflammation. The present report concerns a case p...

Controversies in the treatment of plasma cell myeloma.

Phenotypic consensus markers for plasma cell myeloma

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. http://dx.doi.org/10.5045/kjh.2012.47.4.239 The Korean Journal of Hematology Volume 47ᆞNumbe...

Treatment of Multiple Myeloma

Les traitements classiques de myelome multiple et les schemas differents proposes ont ete mis en revue.  La poly chimiotherapie de la maladie avec une com-binaison de cyclophosphamide, B.C.N.U. Alkeran, Perdnisone et Vincristine a donnee une meilleur Resultat ceci surtout dans les formes graves et rapidement progressive de la maladie. D'autres sehemas therapeutiques sont en cours.